临床药师参与1例二尖瓣钳夹术患者抗栓药物用药实践  

Clinical Pharmacists Participated in the Practice of Using Antithrombotic Drugs in a Patient Undergoing Mitral Valve Clamping

作　　者：林自明 梁学芹 LIN Zi-ming;LIANG Xue-qin(Guangdong clifford hospital,Guangzhou 511495,China)

机构地区：[1]广东祈福医院,广东广州511495

出　　处：《海峡药学》2024年第4期81-83,共3页Strait Pharmaceutical Journal

摘　　要：目的 为二尖瓣反流患者行二尖瓣钳夹术(MitraClip)后提供抗栓药物个体化用药指导。方法 临床药师参与1例二尖瓣反流患者行MitraClip手术的术后抗栓药物治疗过程,分析选择患者的抗栓药物方案,给予用药指导及药学监护,并进行用药教育。结果 MitraClip手术属于心脏病介入治疗,术后抗栓药物的合理应用对降低患者术后血栓形成、卒中、全身性栓塞等并发症的风险十分重要。患者既往无抗凝指征,临床药师建议启用双联抗血小板治疗方案,医师采纳建议。住院期间患者且无栓塞或出血不良事件发生。结论 目前国内外尚无对MitraClip手术标准抗栓治疗的指南或共识。临床药师应根据患者自身的栓塞风险和出血风险,为患者提供个体化抗栓用药方案。OBJECTIVE To provide individualized medication guidance for patients with mitral regurgitation after Mitral Valve Clamping(MitraClip).METHODS Clinical pharmacists participated in the course of postoperative antithrombotic drug treatment of a patient with mitral regurgitation undergoing MitraClip surgery,analyzed and selected the antithrombotic drug scheme of the patient,gave medication guidance and pharmaceutical care,and carried out medication education.RESULTS MitraClip operation belongs to interventional therapy of heart disease,and the rational use of antithrombotic drugs after operation is very important to reduce the risk of postoperative complications such as thrombosis,stroke and systemic embolism.The patient had no indication of anticoagulation in the past,so the clinical pharmacist suggested to start the dual antiplatelet treatment scheme,and the doctor adopted the suggestion.No adverse events such as embolism or bleeding occurred during hospitalization.CONCLUSION At present,there is no guideline or consensus on standard antithrombotic therapy for MitraClip surgery at home and abroad.Clinical pharmacists should provide patients with individualized antithrombotic drugs according to their own embolism risk and bleeding risk.

关 键 词：二尖瓣反流 二尖瓣钳夹术 抗栓药物 

分 类 号：R969[医药卫生—药理学]